BioMelbourne Network
Progressing BioIndustry
News and Opinions
2011
August
Science Needs More Support: Bandt
9th August 2011: The government needs to set a national goal for research and development spending of at least 3% of GDP, Greens MP Adam Bandt told a meeting of the biotechnology industry today. Addressing the breakfast meeting of the BioMelbourne Network at Melbourne’s Federation Square , Mr Bandt said while there had been increased business investment in R&D, government funding was lagging be... read more…
2010
March
PHASE II CLINICAL TRIAL FOR METABOLIC SYNDROME & NASH COMMENCES IN ISRAEL
29 March 2010, Melbourne and Sydney Australia: Immuron (ASX: IMC) has commenced a Phase II clinical trial of its immunotherapy product for the treatment of Metabolic Syndrome and NASH (Nonalcoholic steatohepatitis). The clinical trial is taking place at the Hadassah Hebrew University Medical Centre in Jerusalem under an agreement between Immuron and Hadasit, the Medical Centre’s commercialisati... read more…
2009
August
Overview of U.S. Patent Law Reform Efforts
Jeffrey S Rothstein -Sidley Austin LLP.
Efforts to overhaul the United States patent system are gaining ground. If the reform effort succeeds, the way you obtain and enforce patents in the U.S. will change significantly.
The U.S. House of Representatives and U.S. Senate are now considering separate patent reform bills (H.R. 1260 and S. 515). To become law, a bill must be approved by both ch... read more…
